UCLA research shows promising method for correcting genetic code to treat sickle cell
UCLA stem cell researchers have shown that a novel stem cell gene therapy method could one day provide a one-time, lasting treatment for the most common inherited blood disorder in the U.S - sickle cell disease. The study was published in the journal Blood.
March 02, 2015